GGrantIndex
Sort

130,381 grants matching hiv

LITE CONNECT: Addressing testing gaps and epidemiologic disparities of COVID-19 amongtransgender people in the United States

$1,443,647
Andrea L Wirtz · Johns Hopkins University · UH3 · FY2020 · AI

A comparative evaluation of overdose prevention programs in New York City and Rhode Island

$1,443,604
Magdalena Cerda · New York University School Of Medicine · R01 · FY2025 · DA

HIV Treatment in the homeless: a prospective study

$1,443,598
University Of California San Francisco · R01 · FY2004 · MH

NUTRITION AND HIV INFECTION

$1,443,538
Tufts University Boston · P01 · FY2003 · DK

Primary Infection Resource Consortium (Pirc)

$1,443,529
Susan Little · University Of California, San Diego · R24 · FY2016 · AI

Topical Microbicide Against SIV and Chlamydia

$1,443,416
Ashley T. Haase · University Of Minnesota · R33 · FY2009 · AI

California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations

$1,443,116
Joel Palefsky · University Of California, San Francisco · U54 · FY2019 · CA

Methods Core

$1,442,847
John Schneider · University Of Chicago · U2C · FY2019 · DA

Technology-based Treatments for Substance Use Disorders

$1,442,667
Lisa A Marsch · Dartmouth College · P30 · FY2024 · DA

UCLA AIDS Prevention and Treatment Clinical Trials Unit

$1,442,278
Judith S. Currier · University Of California Los Angeles · U01 · FY2011 · AI

Molecular Analysis of Tuberculosis Immunity

$1,442,274
William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2009 · AI

Immunophilin ligands for HIV dementia and neuropathy

$1,441,957
Johns Hopkins University · P01 · FY2004 · MH

Technology-based Treatments for Substance Use Disorders

$1,441,869
Lisa A Marsch · Dartmouth College · P30 · FY2022 · DA

Technology-based Treatments for Substance Use Disorders

$1,441,869
Lisa A Marsch · Dartmouth College · P30 · FY2023 · DA

Technology-based Treatments for Substance Use Disorders

$1,441,869
Lisa A Marsch · Dartmouth College · P30 · FY2025 · DA

Harvard Medical School Vaccine Clinical Trials Unit

$1,441,738
Raphael Dolin · Harvard Medical School · U01 · FY2007 · AI

HIV & AIDS PREVENTION AND PALLIATIVE CARE FOR TEACHERS, ORPHANS AND VUNERABLE

$1,441,591
Nomfundo Mkhulisi · South African Democratic Teacher'S Union · U2G · FY2010 · PS

PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices

$1,441,456
Lisa B Hightow-Weidman · Florida State University · U01 · FY2023 · PS

Nonhuman primate scientific research support component

$1,441,072
Norman L Letvin · Duke University · UM1 · FY2014 · AI

Economic Opportunity for Zimbabwean Adolescent Orphans

$1,440,928
University Of California San Francisco · R01 · FY2005 · HD

KAPOSI'S SARCOMA: PATHOGENESIS AND NOVEL THERAPY

$1,440,823
University Of Md Biotechnology Institute · P01 · FY2001 · CA

Center for AIDS Research at Emory University-CFAR RYSE Pathway Programs

$1,440,311
Carlos Del Rio · Emory University · P30 · FY2025 · AI

Center for AIDS Research at Emory University Administrative (Revision) Core

$1,440,311
Carlos Del Rio · Emory University · P30 · FY2025 · AI

COLORADO ADULT AIDS CLINICAL TRIALS UNIT

$1,440,022
University Of Colorado Denver · U01 · FY2004 · AI

Refining Trichomonas vaginalis treatment in women and men.

$1,439,941
Patricia J Kissinger · Tulane University Of Louisiana · R01 · FY2024 · AI